StockData
Encompass Health Corp logo

Encompass Health Corp (EHC) stock

EHCNYSEServices-HospitalsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 16/3010% above fair value
$142.11+1.12 (+0.79%)

Close on Nov 16, 2026Market cap $14.02BP/E 23.1Yield 0.51%

Encompass Health operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Encompass Health's operating cash flow for the twelve months ending Jun 30, 2026 was $1.21B, up 9.7% year over year. For fiscal 2025 it was $1.18B, up 17.2% from the year before. Over ten years it grew 8.9% a year on average. The highest annual figure on record is $1.18B in fiscal 2025.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.18B+17.2%
FY2024Dec 31, 2024$1.00B+17.9%
FY2023Dec 31, 2023$850.80M+20.5%
FY2022Dec 31, 2022$705.80M-1.4%
FY2021Dec 31, 2021$715.80M+1.6%
FY2020Dec 31, 2020$704.70M+10.9%
FY2019Dec 31, 2019$635.30M-16.7%
FY2018Dec 31, 2018$762.40M+15.8%
FY2017Dec 31, 2017$658.30M+2.8%
FY2016Dec 31, 2016$640.20M+27.5%
FY2015Dec 31, 2015$502.00M+12.8%
FY2014Dec 31, 2014$444.90M-5.4%
FY2013Dec 31, 2013$470.30M+14.3%
FY2012Dec 31, 2012$411.50M+20.1%
FY2011Dec 31, 2011$342.70M+3.5%
FY2010Dec 31, 2010$331.00M-18.5%
FY2009Dec 31, 2009$406.10M+78.7%
FY2008Dec 31, 2008$227.20M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$282.60M+4.6%
Q1 FY2026Mar 31, 2026$313.10M+8.5%
Q4 FY2025Dec 31, 2025$346.00M+24.1%
Q3 FY2025Sep 30, 2025$270.80M+1.1%
Q2 FY2025Jun 30, 2025$270.20M+24.3%
Q1 FY2025Mar 31, 2025$288.60M+20.9%
Q4 FY2024Dec 31, 2024$278.80M+38.7%
Q3 FY2024Sep 30, 2024$267.80M+24.4%
Q2 FY2024Jun 30, 2024$217.40M+5.2%
Q1 FY2024Mar 31, 2024$238.80M+4.8%
Q4 FY2023Dec 31, 2023$201.00M+16.7%
Q3 FY2023Sep 30, 2023$215.20M+207.0%
Q2 FY2023Jun 30, 2023$206.70M-15.5%
Q1 FY2023Mar 31, 2023$227.90M+4.1%
Q4 FY2022Dec 31, 2022$172.20M+39.1%
Q3 FY2022Sep 30, 2022$70.10M-60.5%
Q2 FY2022Jun 30, 2022$244.60M-4.4%
Q1 FY2022Mar 31, 2022$218.90M+38.1%
Q4 FY2021Dec 31, 2021$123.80M-55.7%
Q3 FY2021Sep 30, 2021$177.60M+2.4%
Q2 FY2021Jun 30, 2021$255.90M+15.1%
Q1 FY2021Mar 31, 2021$158.50M+441.0%
Q4 FY2020Dec 31, 2020$279.70M+29.7%
Q3 FY2020Sep 30, 2020$173.40M+51.6%
Q2 FY2020Jun 30, 2020$222.30M+52.9%
Q1 FY2020Mar 31, 2020$29.30M-81.7%
Q4 FY2019Dec 31, 2019$215.60M+20.9%
Q3 FY2019Sep 30, 2019$114.40M-42.4%
Q2 FY2019Jun 30, 2019$145.40M-14.1%
Q1 FY2019Mar 31, 2019$159.90M-26.1%
Q4 FY2018Dec 31, 2018$178.40M+17.8%
Q3 FY2018Sep 30, 2018$198.50M+13.5%
Q2 FY2018Jun 30, 2018$169.20M+11.9%
Q1 FY2018Mar 31, 2018$216.30M+19.6%
Q4 FY2017Dec 31, 2017$151.40M+7.5%
Q3 FY2017Sep 30, 2017$174.90M-1.5%
Q2 FY2017Jun 30, 2017$151.20M–
Q1 FY2017Mar 31, 2017$180.80M–
Q4 FY2016Dec 31, 2016$140.80M–
Q3 FY2016Sep 30, 2016$177.60M–

More Encompass Health figures

See a number that looks wrong?